miR-107 Inhibits the Proliferation of Gastric Cancer Cells In vivo and In vitro by Targeting TRIAP1.
Saved in:
| Title: | miR-107 Inhibits the Proliferation of Gastric Cancer Cells In vivo and In vitro by Targeting TRIAP1. |
|---|---|
| Authors: | Yan J; Emergency of Department, Changhai Hospital, Shanghai, China., Dai L; The Fourth Outpatient Department, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Yuan J; The Fourth Outpatient Department, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Pang M; The Fourth Outpatient Department, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Wang Y; The Fourth Outpatient Department, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Lin L; Emergency of Department, Changhai Hospital, Shanghai, China., Shi Y; Department of Oral and Maxilliofacial Surgery, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Wu F; Department of Oral and Maxilliofacial Surgery, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Nie R; The Seventh Outpatient Department, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China., Chen Q; Cangnan Hospital Affiliated to Wenzhou Medical University, Wenzhou, China., Wang L; Department of Gastroenterology, Changhai Hospital, Shanghai, China. |
| Source: | Frontiers in genetics [Front Genet] 2022 Apr 11; Vol. 13, pp. 855355. Date of Electronic Publication: 2022 Apr 11 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101560621 Publication Model: eCollection Cited Medium: Print ISSN: 1664-8021 (Print) Linking ISSN: 16648021 NLM ISO Abbreviation: Front Genet Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
